MMedication Read More FDA Approves First Treatment for MAS in Still DiseaseJuly 1, 2025 The FDA has approved the interferon gamma-blocking antibody emapalumab-lzsg (Gamifant) for the treatment of macrophage activation syndrome (MAS)…